Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.
Allison GaudyChristian AtsrikuYing YeKimberly MacGormanLiangang LiuYongjun XueSekhar SurapaneniMaria PalmisanoPublished in: European journal of clinical pharmacology (2020)
Clinical trial identification number is NCT02820935 and was registered in July 2016.